Latham & Watkins represented Clarify Health in the transaction. Clarify Health, a leading cloud analytics and value-based payments platform company, has announced that it secured US$150...
Clarify Health’s $150 Million Series D Financing
Remote’s $300 Million Series C Financing Round
Wilson Sonsini advised Remote on the deal, while Latham & Watkins represented SoftBank Vision Fund 2. Remote, a leader in building, managing, and supporting global, distributed...
Clarify Health’s Acquisition of Embedded Healthcare
Latham & Watkins represented Clarify Health in the transaction. Clarify Health, a leading cloud analytics and value-based payments platform company, has announced the acquisition of Embedded...
dbt Labs’ $222 Million Series D Financing Round
Latham & Watkins represented dbt Labs in the transaction. dbt Labs, the pioneer in analytics engineering, has raised US$222 million in Series D financing at a US$4.2...
Cloudflare’s $162 Million Acquisition of Area 1 Security
Latham & Watkins represented Area 1 Security in the transaction. Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, has...
Standard Metrics’ $23.7 Million Series A Financing
Latham & Watkins represented Standard Metrics in the transaction. Standard Metrics, the data and relationships platform for the private capital markets formerly known as Quaestor, has...
Weee!’s $425 Million Series E Financing
Wilson Sonsini Goodrich & Rosati advised Weee! on the deal, while Latham & Watkins represented SoftBank Vision Fund 2. Weee!, the largest and fastest-growing ethnic e-grocer...
Ventus Therapeutics’ $140 Series C Financing
Latham & Watkins represented SoftBank Vision Fund 2 in the transaction. Ventus Therapeutics, a biopharmaceutical company utilizing structural biology and computational tools to identify and develop small molecule...
Kobold Metals’ $192.5 Million Series B Financing
Latham & Watkins represented Kobold Metals in the transaction. Kobold Metals, an AI powered mineral exploration company, has announced it has raised US$192.5 million in its...
Spotter’s $200 Million Series D Financing
Latham & Watkins represented SoftBank Vision Fund 2 in the transaction. Spotter, the creator platform, announced US$200 million in Series D financing at a valuation of US$1.7...
Innocoll Biotherapeutics’ $125 Million Term Loan Facility
Latham & Watkins represented Innocoll Biotherapeutics in the transaction. Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, has announced the successful...
UPSIDE Foods’ Acquisition of Cultured Decadence
Latham & Watkins represented UPSIDE Foods in transaction. UPSIDE Foods (formerly Memphis Meats), a leading company in the cultivated meat, poultry, and seafood industry, has announced the...